On 4 September 2026 FarmInsect’s co-founder Wolfgang Westermeier confirmed that the Munich company is being wound down. Its insolvency administrator put it more precisely to top agrar the following day: after long talks with several interested buyers, no agreement on a takeover of the business was reached, operations have been completely ended, and what is left of the company’s intangible assets is now to be realised.
FarmInsect was not another mega-factory. It was the company that sold the opposite thesis. Its October 2023 Series A release said so in terms: “In contrast to most insect farming companies today who are building mega-factories, FarmInsect wants to decentralize production”. Farmers bought a modular rearing unit, received weekly shipments of seed larvae, fattened them on their own residues and fed the result to their own animals. The lead investor, Sandwater, said it had backed FarmInsect precisely because the existing insect model “involves substantial capital investment and has proven difficult to scale” and this was “a commercially available, low capex solution”.
That is why this closure matters more than its size. The Insect Institute’s June tally of the sector’s failures lists five companies and $777 million of capital: Aspire, Enorm, Ÿnsect and AgroLoop, all centralised, and Goterra, the one decentralised entrant. Goterra went into voluntary administration on 3 June 2026. FarmInsect’s operations ended within three months of it. Both of the models the industry proposed as the fix for the centralised failures have now failed, and the second failed with an EU-funded project on the record saying the model worked.
The timeline, from the filings
| Date | Event | Source |
|---|---|---|
| 2020 | FarmInsect GmbH founded in Munich by Thomas Kuehn, Wolfgang Westermeier and Andre Klöckner | top agrar, 8 April 2026 |
| 25 November 2022 | Selected by the EIC Accelerator: €2.5m grant plus €5m of EIC Fund equity “in the next funding round” | Munich Startup |
| 21 December 2022 | EU grant agreement 190164847 signed; project runs 1 January 2023 to 31 December 2024 | CORDIS |
| 23 October 2023 | €8m Series A led by Sandwater, with Bayern Kapital, Minderoo Foundation and the EIC Fund | FarmInsect release |
| End of 2024 | Internal restructuring to cut costs, refocus on what it called “industrielle Unit Economics” | Anchor press release |
| 2024 financial year | Loss of about €3.1m (2023: €3.3m); about €11m raised in total by end-2024 | top agrar, citing deutsche-startups.de |
| September 2025 | AGRAVIS Raiffeisen suspends its Flyvis Farming collaboration with FarmInsect | Aquafeed.com |
| 20 March 2026 | Insolvency application filed with the Munich District Court | Aquafeed.com |
| 25 March 2026 | Court orders provisional administration; Dr Alexander Zarzitzky of Anchor appointed | Anchor press release |
| 1 April 2026 | Administrator announces a structured investor process, transaction targeted for the end of May 2026 | Anchor press release |
| 1 June 2026 | Formal insolvency proceedings opened “due to inability to pay” | Aquafeed.com |
| 4 to 5 September 2026 | Westermeier confirms the wind-down; administrator confirms operations “komplett eingestellt” | Aquafeed.com; top agrar |
Two of the dates conflict. Aquafeed, citing the court, puts the application on 20 March; Anchor’s own release says the court ordered provisional administration on 25 March, which is consistent with a filing a few days earlier. But top agrar’s 5 September piece says the application was made “Im April 2026”. We have used the March dates, because the administrator’s release is dated 1 April and already describes the order of 25 March as made. We flag the discrepancy rather than resolve it.
Practical consequence. The interval from filing to formal opening was ten weeks, and from opening to wind-down another three months. Anyone holding a supply or offtake relationship with a German insolvent counterparty should read the provisional administrator’s first release for the date the investor process is meant to close, and treat that date, not the opening of proceedings, as the moment the business either has a buyer or does not. Here the target was the end of May. No buyer was announced then, and the formal opening on 1 June was the tell.
What the money was, and what it bought
The administrator’s release gives the total: about €16.2 million of equity and public funding since foundation. top agrar repeats the same figure. Neither breaks it down, and FarmInsect’s own announcements only cover part of it.
| Component | Amount | Type | Source |
|---|---|---|---|
| EIC Accelerator grant, project 190164847 | €2,499,999 | Non-dilutive grant | CORDIS fact sheet |
| EIC Fund equity, announced with the grant | €5m, “in the next funding round” | Equity | Munich Startup, November 2022 |
| Series A, October 2023 | €8m, oversubscribed | Equity | FarmInsect release |
| Earlier rounds (HTGF, UnternehmerTUM, Bayern Kapital’s first stake “around two years” before October 2023) | Not disclosed | Equity | FarmInsect release |
| European Investment Bank | Named as a public funder; amount and instrument not disclosed | Not stated | Anchor press release |
The EIC Fund’s €5 million and the €8 million Series A are not additive on the face of the documents: the EIC Fund is listed as a participant in the Series A, so some or all of its equity commitment was drawn inside that round. That is the reading most consistent with top agrar’s figure of about €11 million by end-2024 — the €8 million round plus the €2.5 million grant plus earlier seed money — and with the €16.2 million total only if something in the order of €5 million arrived in 2025, the year for which no financing announcement exists. We could not establish what that was. Anchor’s release says the crisis was triggered by a delay in the payout of an agreed financing tranche (“einer Verzögerung bei der Auszahlung einer vereinbarten Finanzierungstranche”), which implies a facility that was agreed and only partly drawn; whether that was the EIB, the EIC Fund or a shareholder loan is not stated.
The grant itself is the best-documented part. CORDIS records a total project cost of €3,575,125 against an EU contribution of €2,499,999, a 70% funding rate, for a project whose stated objective was that “a livestock farmer can produce up to 1.000tn/yr of BSF larvae at €800 vs. 1.350€/t of fishmeal”. That sentence was written in 2022. Hold it against the administrator’s April 2026 description of a company that “steht kurz davor, die Kostenparität zu herkömmlichem Fischmehl zu erreichen” — is on the verge of reaching cost parity with conventional fishmeal. In the funding application the larvae were 41% cheaper than fishmeal. Four years and €16 million later they were approaching parity, and the administrator listed “geringe Preise für Soja und Fischmehl” — low soy and fishmeal prices — as the first cause of the collapse.
Practical consequence. A cost claim in a grant application is an input to a funding decision, not a measured result. When the same company’s administrator later describes the same product as approaching parity, the earlier number should be treated as withdrawn. Anyone modelling insect meal against fishmeal should use the later statement.
The EU report that said the model was profitable
The most uncomfortable document in this record is the project’s own final reporting. The CORDIS periodic report for 2024, last updated on 1 June 2025, states that “the business model validation confirmed that decentralized BSF farming can be both profitable and environmentally sustainable, providing farmers with a new revenue stream”. It describes automated climate control, feeding and harvesting; a young-larvae transport system that “significantly lowers logistics costs”; feeding trials in poultry and pigs; and business model validation.
The report covers a year in which, according to top agrar’s account of the accounts, the company lost about €3.1 million, and at the end of which, according to its own administrator, it had already begun an internal restructuring to cut costs. Nine months after the report’s last update, the company filed for insolvency. The report is not false — a model can be profitable for the farmer running the unit and unprofitable for the company supplying the unit, the larvae and the software — but that is exactly the distinction the sentence elides. Profitable for whom is the question, and the answer that mattered was the vendor.
This is not unique to FarmInsect. AgNavigator’s June coverage of Goterra records that the Australian company generated AUD1.2 million of revenue in its 2025 financial year against AUD14 million of expenses, alongside about AUD5.3 million of grant funding, and had raised USD25.2 million by PitchBook’s count. The Insect Institute’s Dustin Crummett asked the obvious question: “it is reasonable to ask why they still needed more runway from investors, given how long the company has been in business and how much support they have received.”
Practical consequence. Public-funding reports are written by the grantee and assess the project against its own work plan. They are useful for what was built and useless for whether the company is solvent. Read them for the technical claims, and read the Bundesanzeiger accounts, where they exist, for the rest.
Why the decentralised model did not escape the centralised problem
The centralised failures share a shape the Insect Institute summarised for AgroLoop: “construction of a large insect protein plant consumed available funds before production reached commercial scale, and once operational, revenues could not cover financing costs.” Ÿnsect’s Poulainville plant is the extreme case, and our August analysis of what remained of it found a 200,000-tonne facility whose selling point had become its grid connection.
Decentralisation was meant to remove the capex. What FarmInsect’s record shows is that it moved the problem rather than removing it. The company still had to develop and hold the breeding lines, run a hatchery, ship seed larvae weekly, build and maintain automated units, and write the software that guided each customer through production. It carried the fixed cost of a platform while the revenue arrived one farm at a time. The administrator’s release says the company had “vier aktive Farmstandorte” — four active farm sites — in April 2026, and top agrar confirms four agricultural businesses were rearing larvae for it in September. Four sites, after five years and €16.2 million, is the number.
The demand side is the other half. The distribution partner that was meant to bring the model to German farms, AGRAVIS Raiffeisen, suspended the Flyvis Farming collaboration in September 2025, six months before the filing. Its spokesman told top agrar, in Aquafeed’s account, that the decision reflected insufficient demand and a lack of competitiveness for insect protein, alongside regulatory hurdles, and that the planned installations with farmers never materialised. A company selling farm units through an agricultural cooperative cannot survive that cooperative deciding the product is a “niche”.
Goterra’s version of the same story is the feedstock. Its units processed customer food waste for a gate fee; Crummett’s explanation of why that fails is that low and inconsistent feedstock gives “higher mortality rates, longer growing times, and ultimately a low-quality and inconsistent product”, and that supplementing with better feed “adds a level to the food chain”. FarmInsect’s CORDIS report names grape and elderberry pomace as feedstocks. Whether its larvae met a consistent specification across four farms on such inputs is not something any of the documents says.
Practical consequence. For a feed buyer, a decentralised insect supplier is a platform company with a hatchery, not a farmer. Its unit economics are the platform’s, and its supply depends on the number of sites it can sign, service and keep. Ask for the site count and the churn, not the per-farm payback.
The case that this is not the model’s fault
The administrator’s account deserves to be read on its own terms. It attributes the insolvency to a market environment of low soy and fishmeal prices, high production costs, and a specific liquidity gap caused by a delayed financing tranche. It says the company had already refocused on industrial unit economics, was close to fishmeal parity, and planned to expand into the US pet-food and poultry-feed markets. On that reading FarmInsect was a viable platform that ran out of cash between two tranches at the wrong point in the commodity cycle, and a buyer could have taken it on.
The trouble with that reading is that the buyer did not come. The investor process was run by a specialist M&A adviser, targeted the end of May, and by early September had ended with talks only about intangible assets. Strategic buyers seeking, in the administrator’s April description, a fast entry into the insect protein market looked at a platform with four sites and did not pay for it. That is a market verdict on the model, not only on the balance sheet.
There is also a broader defence, which is that six failures out of a global population of companies proves nothing about the survivors, and that Innovafeed and Protix continue to operate the largest centralised plants. That is true. It is also the point: the companies still standing are the ones that built big, not the ones that promised to avoid it.
What we could not establish
- The filing date. Aquafeed and the administrator’s release support 20 to 25 March 2026; top agrar says April. We have used March and noted the conflict.
- The breakdown of the €16.2 million. We can account for €10.5 million from published documents (the €2.5 million grant and the €8 million Series A) and about €11 million by end-2024 from top agrar’s figure. The remaining roughly €5 million, the EIB’s instrument and amount, and the identity of the delayed financing tranche are not disclosed.
- Whether the EIC Fund’s €5 million was fully drawn. It is listed as a Series A participant; how much of the announced commitment it invested is not stated.
- The 2024 and 2025 accounts. The 2024 loss of about €3.1 million is top agrar’s figure, attributed to deutsche-startups.de; we did not retrieve the Bundesanzeiger filing. No 2025 figures are public.
- Enorm’s date. The Insect Institute gives November 2025 for the bankruptcy declaration; Aquafeed says October 2025. We have not resolved it and have used the Institute’s table as the primary comparator.
- Revenue. No FarmInsect revenue figure appears in any document we read.
What to watch
- The Munich insolvency register for the opening of asset realisation and any sale of the breeding lines, hatchery equipment or software. The administrator says talks on intangibles are ongoing. A buyer for the IP without the sites would confirm that the platform, not the technology, was the problem.
- Goterra’s administration outcome. If the Australian decentralised model also fails to find a buyer for the business, two decentralised entrants will have closed with no successor in the same quarter.
- Whether Innovafeed’s or Protix’s next financing carries a disclosed offtake. The centralised survivors are the sector’s remaining test, and the question the failures leave is whether anyone will underwrite capacity without a signed buyer.
- The four German farms. The administrator said it would try to connect them with comparable larvae suppliers. If they are still rearing insects in twelve months, the farm-level economics held even when the vendor’s did not.